Satrajit Roychoudhury

Satrajit Roychoudhury

Pfizer Inc. - New York / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4381870
-
person_outline Satrajit Roychoudhury's MOST POPULAR ARTICLES
1-) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccineFP Polack, SJ Thomas, N Kitchin, J Absalon, A Gurtman, S Lockhart, ...New England journal of medicine, 2020103482020
2-) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 monthsSJ Thomas, ED Moreira Jr, N Kitchin, J Absalon, A Gurtman, S Lockhart, ...New England Journal of Medicine 385 (19), 1761-1773, 20217602021
3-) Use of historical control data for assessing treatment effects in clinical trialsK Viele, S Berry, B Neuenschwander, B Amzal, F Chen, N Enas, B Hobbs, ...Pharmaceutical statistics 13 (1), 41-54, 20143302014
4-) Robust meta-analytic-predictive priors in clinical trials with historical control informationH Schmidli, S Gsteiger, S Roychoudhury, A O\'Hagan, D Spiegelhalter, ...Biometrics 70 (4), 1023-1032, 20144312014
5-) Robust exchangeability designs for early phase clinical trials with multiple strataB Neuenschwander, S Wandel, S Roychoudhury, S BaileyPharmaceutical statistics 15 (2), 123-134, 20161652016